Related Experiment Video
Updated: May 17, 2025

Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
Helicobacter heilmannii Infection With Concurrent Gastric Cancer: A Case Report
Tomohiro Kamio1, Yoshiyasu Kono1, Masaya Iwamuro2
1Department of Gastroenterology and Hepatology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, JPN.
Abstract:
Helicobacter heilmannii (H. heilmannii), a zoonotic pathogen, is increasingly recognized as a cause of gastritis and a potential risk factor for gastric cancer, despite its rarity. Here, we report a case of multiple synchronous early gastric cancers in a female patient in her 40s with H. heilmannii-associated gastritis. She underwent an esophagogastroduodenoscopy (EGD) for the evaluation of gastric discomfort. Endoscopy revealed cobblestone-like gastritis. Histological examination confirmed a signet ring cell carcinoma. Helicobacter pylori (H. pylori) antibody test was negative, and spiral-shaped bacteria were detected by Giemsa staining and real-time polymerase chain reaction (PCR), confirming H. heilmannii infection. Endoscopic submucosal dissection achieved curative resection without recurrence. Helicobacter heilmannii-induced gastritis presents distinct features, including a cobblestone-like appearance and lymphocyte-dominant infiltration, differing from H. pylori-associated gastritis. Chronic inflammation and immune modulation caused by H. heilmannii infection may contribute to carcinogenesis. Considering the diagnostic challenges and zoonotic transmission risks, enhanced awareness of H. heilmannii-associated gastric cancer is essential. This case highlights the importance of identifying H. heilmannii in H. pylori-negative gastritis and its potential role in gastric carcinogenesis. Further research is required to elucidate the pathogenic mechanisms and establish effective management protocols.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

